Advisor Partners II’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$393K Sell
31,918
-429
-1% -$6.38K 0.02% 825
2023
Q2
$520K Sell
32,347
-1,823
-5% -$30K 0.02% 595
2023
Q1
$595K Buy
34,170
+10,761
+46% +$153K 0.03% 486
2022
Q4
$216K Buy
+23,409
New +$218K 0.01% 823

Other funds holding NEO

Advisor Partners II's NEO Position: Q3 2023 in Review

Advisor Partners II reduced its NeoGenomics (NEO) stake by 1.3% in Q3 2023, selling an estimated $6.38K and leaving 31,918 shares worth $393K. The position accounts for 0.02% of the portfolio, ranked #825.

Advisor Partners II first reported a position in NEO in Q4 2022 and has held it in 4 quarters since. The position peaked at $595K in Q1 2023. 283 funds tracked by Wall St. Rank hold NEO as of Q3 2023.

  • Advisor Partners II held 31,918 shares of NeoGenomics worth $393K as of Q3 2023.
  • Advisor Partners II sold 429 NeoGenomics shares in Q3 2023, an estimated $6.38K.
  • NeoGenomics made up 0.02% of Advisor Partners II's portfolio in Q3 2023, its #825 holding.
  • Advisor Partners II first reported a position in NeoGenomics in Q4 2022 and has held it in 4 quarters since.
  • Advisor Partners II's NeoGenomics position peaked at $595K in Q1 2023.
  • 283 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.